This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Janssen Sciences Ireland Uc. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Steffen Friedrich Walter Weidner: Innovator in Antibacterial Compounds
Introduction
Steffen Friedrich Walter Weidner is a notable inventor based in Illkirch-Graffenstaden, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial compounds. His work focuses on innovative solutions to combat bacterial infections.
Latest Patents
Weidner holds a patent for novel antibacterial compounds that inhibit the activity of the FabI enzyme. This invention is crucial for the treatment of bacterial infections and includes pharmaceutical compositions comprising these compounds, as well as the chemical processes for their preparation.
Career Highlights
Weidner is currently associated with Janssen Sciences Ireland UC, where he continues to advance his research and development efforts in the pharmaceutical industry. His expertise in antibacterial compounds has positioned him as a valuable asset in the fight against infectious diseases.
Collaborations
Throughout his career, Weidner has collaborated with esteemed colleagues such as Jerôme Emile Georges Guillemont and David Francis Alain Lançois. These partnerships have fostered innovation and contributed to the success of his research endeavors.
Conclusion
Steffen Friedrich Walter Weidner's work in developing antibacterial compounds showcases his commitment to improving healthcare through innovation. His contributions are vital in addressing the challenges posed by bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile